Yuichiro Higaki

HER‐2/<i>neu</i> gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic <i>in‐situ</i> hybridization study

Kazuki Hashimoto, Hidetaka Yamamoto, Hideki Shiratsuchi et al. · Histopathology · 2012 · 59 citations

Medicine, Molecular Biology, Oncology +17

<i><scp>HER</scp>2</i> and <i><scp>EGFR</scp></i> gene copy number alterations are predominant in high‐grade salivary mucoepidermoid carcinoma irrespective of <i><scp>MAML</scp>2</i> fusion status

Takafumi Nakano, Hidetaka Yamamoto, Kazuki Hashimoto et al. · Histopathology · 2013 · 55 citations

Medicine, Molecular Biology, Oncology +17

Randomized Phase III Trial of Adjuvant Chemotherapy with S-1 after Curative Treatment in Patients with Squamous-Cell Carcinoma of the Head and Neck (ACTS-HNC)

Kiyoaki Tsukahara, Akira Kubota, Yasuhisa Hasegawa et al. · PLoS ONE · 2015 · 45 citations · Full text

Medicine, Oncology, Chemotherapy +15

Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors

Makoto Shinoto, Yoshiyuki Shioyama, Katsumasa Nakamura et al. · Journal of Radiation Research · 2013 · 31 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients with Advanced Head and Neck Cancer

Takeichiro Aso, Mioko Matsuo, Hideyuki Kiyohara et al. · PLoS ONE · 2015 · 28 citations · Full text

Medicine, Oncology, Radiation Oncology +16